JP Morgan Chase’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-1,086,515
Closed -$354M – 7850
2024
Q1
$354M Sell
1,086,515
-11,979
-1% -$2.94M 0.03% 480
2023
Q4
$209M Buy
1,098,494
+212,717
+24% +$40.2M 0.02% 599
2023
Q3
$176M Buy
885,777
+50,639
+6% +$12M 0.02% 594
2023
Q2
$238M Sell
835,138
-438,609
-34% -$122M 0.03% 505
2023
Q1
$276M Buy
1,273,747
+467,237
+58% +$91M 0.03% 438
2022
Q4
$166M Sell
806,510
-118,725
-13% -$30M 0.02% 578
2022
Q3
$257M Sell
925,235
-194,376
-17% -$49.4M 0.04% 416
2022
Q2
$214M Sell
1,119,611
-52,615
-4% -$9.29M 0.03% 486
2022
Q1
$243M Sell
1,172,226
-37,432
-3% -$6.17M 0.03% 505
2021
Q4
$216M Sell
1,209,658
-73,225
-6% -$14.4M 0.02% 540
2021
Q3
$264M Sell
1,282,883
-260,880
-17% -$51.2M 0.03% 493
2021
Q2
$293M Sell
1,543,763
-168,948
-10% -$27.6M 0.03% 488
2021
Q1
$223M Sell
1,712,711
-161,376
-9% -$19.4M 0.03% 537
2020
Q4
$194M Buy
1,874,087
+10,797
+0.6% +$935K 0.03% 539
2020
Q3
$139M Buy
1,863,290
+3,417
+0.2% +$194K 0.02% 583
2020
Q2
$88.1M Buy
1,859,873
+445,985
+32% +$18.4M 0.02% 690
2020
Q1
$46.9M Buy
1,413,888
+282,476
+25% +$11.2M 0.01% 826
2019
Q4
$49.7M Buy
1,131,412
+666,815
+144% +$24.6M 0.01% 967
2019
Q3
$13.9M Buy
464,597
+191,251
+70% +$8.12M ﹤0.01% 1868
2019
Q2
$15M Sell
273,346
-57,466
-17% -$2.79M ﹤0.01% 1778
2019
Q1
$11.1M Buy
+330,812
New +$11M ﹤0.01% 1959

Other funds holding SWAV

JP Morgan Chase's SWAV Position: Q2 2024 in Review

JP Morgan Chase sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 1,086,515 shares — an estimated $354M sold.

JP Morgan Chase first reported a position in SWAV in Q1 2019 and held it in 21 quarters. The position peaked at $354M in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • JP Morgan Chase reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • JP Morgan Chase sold 1,086,515 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $354M.
  • JP Morgan Chase first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2019 and held it in 21 quarters.
  • JP Morgan Chase's Shockwave Medical, Inc. Common Stock position peaked at $354M in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on JP Morgan Chase's 13F filing for Q2 2024, filed 12 Aug 2024.